CA Patent

CA2471566A1 — Combination of mtp inhibitors or apob-secretion inhibitors with fibrates for use as pharmaceuticals

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2003-07-17 · 23y expired

What this patent protects

The invention relates to the use of fibrates for reducing the hepatic toxicity of MTP inhibitors and to pharmaceutical compositions that contain an MTP inhibitor and a fibrate.

USPTO Abstract

The invention relates to the use of fibrates for reducing the hepatic toxicity of MTP inhibitors and to pharmaceutical compositions that contain an MTP inhibitor and a fibrate.

Drugs covered by this patent

Patent Metadata

Patent number
CA2471566A1
Jurisdiction
CA
Classification
—
Expires
2003-07-17
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.